CONMED awards 18,563 RSUs to general counsel

Foust Hollie K reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Foust Hollie K reported acquisition or exercise transactions in this Form 4 filing.

CONMED Corporation granted General Counsel and Corporate Secretary Hollie K. Foust 18,563 restricted stock units (RSUs) under its 2025 Long-Term Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs generally vest over three years, with 33% vesting after one year, another 33% in the second year, and 34% in the third year. This Form 4/A amends a prior report to correct the grant amount, noting that a special award of 7,644 RSUs was added to the originally reported 10,919 RSUs to reach the total of 18,563 RSUs.

Insider Trade Summary

Grant/Award: 18,563 shares

Grant/Award 1 txn

Insider Foust Hollie K

Role General Counsel & Corp Sec

Type	Security	Shares	Price	Value
Grant/Award	RSUs (Restricted Stock Units)	18,563	$0.00	$0.00

Holdings After Transaction: RSUs (Restricted Stock Units) — 18,563 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
2. F2. This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 10,919 shares for a total of 18,563 RSUs granted.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CONMED (CNMD) report about Hollie K. Foust’s equity compensation?

CONMED reported that General Counsel and Corporate Secretary Hollie K. Foust received a grant of 18,563 restricted stock units. These RSUs are compensation under the 2025 Long-Term Incentive Plan and represent a contingent right to receive an equal number of CONMED common shares over time.

How many RSUs were ultimately granted to Hollie K. Foust by CONMED (CNMD)?

Hollie K. Foust was ultimately granted 18,563 restricted stock units in total. The filing explains this consists of the originally reported 10,919 RSUs plus a special additional award of 7,644 RSUs, bringing the corrected aggregate grant to 18,563 RSUs.

What is the vesting schedule for Hollie K. Foust’s 18,563 CONMED (CNMD) RSUs?

The 18,563 RSUs generally vest over a three-year period. According to the filing, 33% of the RSUs vest one year after the grant date, another 33% vest in the second year, and the remaining 34% vest in the third year, subject to plan terms.

What does each CONMED (CNMD) RSU granted to Hollie K. Foust represent?

Each restricted stock unit represents a contingent right to receive one share of CONMED common stock. The RSUs carry no purchase price, are granted under the 2025 Long-Term Incentive Plan, and will convert into common shares as they vest over the three-year schedule described.

Why did CONMED (CNMD) file an amended Form 4/A for Hollie K. Foust?

The amended Form 4/A was filed solely to correct the number of RSUs granted. It clarifies that, in addition to 10,919 originally reported RSUs, a special award of 7,644 RSUs was also granted, resulting in a total of 18,563 restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 01:58 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foust Hollie K

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FL 33773

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel & Corp Sec

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSUs (Restricted Stock Units)	$0	03/02/2026		A		18,563		(1)	03/02/2036	Common Stock	18,563(2)	$0	18,563	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

2. This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 10,919 shares for a total of 18,563 RSUs granted.

	/s/ Thomas Fistek for Hollie K. Foust by Power of Attorney	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.